Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.51 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.51 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALB | P02768 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.38 |
| ▸ | ERN1 | O75460 | 1/20 | 0.37 |
| ▸ | TNF | P01375 | 1/20 | 0.37 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | STAT3 | P40763 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.37 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19358277 | 0.87 | TRIM24 (0.53) | TYRTRIM24TRIM33POLBMAPT | |
| SCHEMBL19358286 | 0.82 | TYR (0.51) | TYRTRIM24TRIM33POLBMAPT | |
| SCHEMBL2558549 | 0.82 | ALB (0.57) | TYRTRIM24TRIM33POLBMAPT | |
| SCHEMBL3195593 | 0.81 | TYR (0.57) | TYRTRIM24TRIM33POLBMAPT | |
| SCHEMBL4556765 | 0.81 | TYR (0.62) | TYRTRIM24TRIM33POLBMAPT | |
| SCHEMBL10584941 | 0.80 | TYR (0.59) | TYRTRIM24TRIM33POLBMAPT | |
| SCHEMBL20339391 | 0.79 | TYR (0.63) | TYRTRIM24TRIM33POLBMAPT | |
| SCHEMBL16873694 | 0.79 | TYR (0.54) | TYRTRIM24TRIM33POLBMAPT | |
| SCHEMBL22146620 | 0.79 | TYR (0.63) | TYRTRIM24TRIM33POLBMAPT | |
| SCHEMBL7323609 | 0.79 | TRIM24 (0.58) | TYRTRIM24TRIM33POLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11149058-B2 | Multi-functional chemical agents, and the method for protein modification | DEPARTMENT OF BIOTECHNOLOGY (IN) | 2021-10-19 | — | — | US | disclosed |
| US-20210163526-A9 | Multi-Functional Chemical Agents, and the Method for Protein Modification | DEPARTMENT OF BIOTECHNOLOGY (IN) | 2021-06-03 | — | — | US | disclosed |
| US-20190085020-A1 | Multi-Functional Chemical Agents, and the Method for Protein Modification | DEPARTMENT OF BIOTECHNOLOGY (IN) | 2019-03-21 | — | — | US | disclosed |
| EP-3442987-A1 | MULTI-FUNCTIONAL CHEMICAL AGENTS, AND THE METHOD FOR PROTEIN MODIFICATION | Department of Biotechnology (IN) | 2019-02-20 | — | — | EP | disclosed |
| WO-2017158612-A1 | MULTI-FUNCTIONAL CHEMICAL AGENTS, AND THE METHOD FOR PROTEIN MODIFICATION | DEPARTMENT OF BIOTECHNOLOGY (IN) | 2017-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11149058-B2 | Multi-functional chemical agents, and the method for protein modification | FN1, LCP1, NPM1 | TYR 4318/4885TRIM24 447/4885TRIM33 2240/4885 |
| US-20190085020-A1 | Multi-Functional Chemical Agents, and the Method for Protein Modification | FN1, LCP1, NPM1 | TYR 4318/4885TRIM24 447/4885TRIM33 2240/4885 |
| US-20210163526-A9 | Multi-Functional Chemical Agents, and the Method for Protein Modification | FN1, LCP1, NPM1 | TYR 4318/4885TRIM24 447/4885TRIM33 2240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.